INSIGHTS ON QUALITY CONTROL

• Quality By Design In The Pharmaceutical Industry

  Real-time release and digital quality management, powered by PAT, are driving efficiency and compliance, reshaping how manufacturers achieve speed, consistency, and competitive advantage.

• The Effects Of Tubing Length On Airborne Particulate Sampling

  Tubing between sampling point and counter quietly shapes what gets measured. Half-micron counts barely flinch, but five-micron particles tell a very different story.

• Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy

  The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.

• Factory Acceptance Testing (FAT): Pre-Shipment Quality Verification Guide

  Quality control begins long before installation. Discover how pre-shipment testing mitigates risk, ensures specification compliance, and streamlines cleanroom project timelines.

• Material Transfer Into A Cleanroom: How To Reduce Contamination Risk At Every Step

  4/20/2026

  Evaluate packaging integrity and master wiping techniques to prevent cleanroom contamination. Focus on surface coverage and controlled transfer paths to ensure consistent product safety and quality.

• Quantitative Determination Of Amorphous And Crystalline Drug In Polymer Microspheres

  12/30/2024

  Biodegradable polymer microspheres control drug release through crystalline and amorphous properties, analyzed using DSC, MDSC, and TGA to determine composition and stability for precise delivery.

• Secondary Packaging: Cartoning And Kitting

  6/23/2026

  Fast deployment, scalable production, and rigorous quality control enabled the delivery of over 20 million complex kits in eight months, demonstrating how efficient operations can meet urgent demand.

• Predicting Drug-Loading Limits In Tablet Formulations

  7/15/2026

  Learn how predictive percolation modeling identified critical drug-loading limits of ~20% for crystalline API and ~15% for SDD forms, cutting tablet formulation trial-and-error significantly.

• Late‑Stage Progress In Excipients For Precision Nanomedicine

  5/6/2026

  View late‑stage development and GMP manufacturing of novel excipients for nanomedicines, emphasizing regulatory rigor, process optimization, analytics, and scale‑up for lipid‑based delivery systems.